Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer.
AIM: Several multigene expression-based tests offering prognostic and predictive information in hormone-receptor positive early breast cancer were established during the last years. These tests provide prognostic information on distant recurrences and can serve as an aid in therapy decisions. We ana...
Main Authors: | Zsuzsanna Varga, Peter Sinn, Florian Fritzsche, Arthur von Hochstetter, Aurelia Noske, Peter Schraml, Christoph Tausch, Andreas Trojan, Holger Moch |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3591350?pdf=render |
Similar Items
-
Correction: Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer.
by: Zsuzsanna Varga, et al.
Published: (2013-01-01) -
Correction: Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer
Published: (2013-01-01) -
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®
by: Richard Buus, et al.
Published: (2021-02-01) -
Early Diagnostic Prediction of Infective Endocarditis: Development and Validation of EndoPredict-Dx
by: Milena Ribeiro Paixão, et al.
Published: (2024-11-01) -
Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results
by: Aurelia Noske, et al.
Published: (2020-02-01)